Partial Glycosylation at Asparagine-2181 of the Second C-Type Domain of Human Factor V Modulates Assembly of the Prothrombinase Complex
- 1 August 1999
- journal article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 38 (35) , 11448-11454
- https://doi.org/10.1021/bi991275y
Abstract
Thrombin-activated factor Va exists as two isoforms, factor Va1 and factor Va2, which differ in the size of their light chains and their affinity for biological membranes. The heterogeneity of the light chain remained following incubation of factor Va with N-glycanase. However, we found that the factor V C2 domain, which contains a single potential glycosylation site at Asn-2181, was partially glycosylated when expressed in COS cells. To confirm the structural basis for factor Va1 and factor Va2, we mutated Asn-2181 to glutamine (N2181Q) and expressed this mutant using a B domain deletion construct (rHFV des B) in COS cells. Thrombin activation of N2181Q released a light chain with mobility identical to that of factor Va2 on SDS−PAGE. The functional properties of purified N2181Q were similar to those of factor Va2 in prothrombinase assays carried out in the presence of limiting concentrations of phosphatidylserine. The binding of human factor Va1 and factor Va2 to 75:25 POPC/POPS vesicles was also investigated in equilibrium binding assays using proteins containing a fluorescein-labeled heavy chain. The affinity of human factor Va2 binding to POPC/POPS vesicles was approximately 3-fold higher than that of factor Va1. These results indicate that partial glycosylation of factor V at asparagine-2181 is the structural basis of the light chain doublet and that the presence of this oligosaccharide reduces the affinity of factor Va for biological membranes.Keywords
This publication has 23 references indexed in Scilit:
- Mutants of Human Choriogonadotropin Lacking N-Glycosyl Chains in the α-Subunit. 1. Mechanism for the Differential Action of the N-Linked CarbohydratesBiochemistry, 1997
- Human Factor Va1 and Factor Va2: Properties in the Procoagulant and Anticoagulant PathwaysBiochemistry, 1997
- The effects of variable glycosylation on the functional activities of ribonuclease, plasminogen and tissue plasminogen activatorBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1995
- Thrombin-Catalyzed Activation of Recombinant Human Factor VBiochemistry, 1995
- Characterization of an acquired inhibitor to coagulation factor V. Antibody binding to the second C-type domain of factor V inhibits the binding of factor V to phosphatidylserine and neutralizes procoagulant activity.Journal of Clinical Investigation, 1992
- Expression and characterization of recombinant human factor V and a mutant lacking a major portion of the connecting regionBiochemistry, 1990
- Cloning of cDNAs coding for the heavy chain region and connecting region of human factor V, a blood coagulation factor with four types of internal repeatsBiochemistry, 1987
- Deglycosylation of asparagine-linked glycans by peptide:N-glycosidase FBiochemistry, 1985
- Human coagluation factor V purification and thrombin-catalyzed activation.Journal of Clinical Investigation, 1980
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970